FierceBiotech9h
AHA 2024: Boston Scientific, Abbott tout long-term heart occluder data
Abbott’s Amulet IDE trial put its left atrial appendage closure device up against the Watchman 2.5, which was approved by the ...
Zacks.com on MSN12h
Boston Scientific Stock Set to Gain From Completion of Axonics Deal
Boston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical technology company focused on the development and commercialization of differentiated devices to treat ...
MassDevice4d
Boston Scientific finalizes $3.7B acquisition of Axonics
Boston Scientific (NYSE: BSX) today announced the completion of its $3.7 billion acquisition of Axonics, Inc. (Nasdaq: AXNX).
health.economictimes.indiatimes15h
Boston Scientific launches multi-functional imaging system AVVIGO
AVVIGO is an intravascular ultrasound (IVUS) and fractional flow reserve (FFR) system designed to provide high-quality IVUS ...
Pharmabiz14h
Boston Scientific WATCHMAN FLX LAAC device demonstrates superior bleeding risk reduction to OAC following a cardiac ablation in OPTION clinical trial
Marlborough, Massachusetts Tuesday, November 19, 2024, 17:00 Hrs [IST] ...
Orange County Business Journal1d
Boston Scientific Completes $3.7B Acquisition of Axonics
Boston Scientific Corp. last week announced that it has closed on its acquisition of Irvine-based medical device maker ...
Boston Scientific (BSX) Gets a Buy from Truist Financial
In a report released today, Richard Newitter from Truist Financial assigned a Buy rating to Boston Scientific (BSX – Research Report). The ...
bovnews1d
What’s Causing Boston Scientific Corporation (BSX) Stock’s 16.53% Jump Over the Last Six Months?
On Friday, Boston Scientific Corporation (BSX) stock saw a decline, ending the day at $86.99 which represents a decrease of $-0.60 or -0.69% from the prior close of $87.59. The stock opened at $87.12 ...